JAZZ logo

JAZZ
Jazz Pharmaceuticals plc

4,171
Mkt Cap
$14.77B
Volume
1.77M
52W High
$243.32
52W Low
$105.00
PE Ratio
-12,792.39
JAZZ Fundamentals
Price
$236.49
Prev Close
$235.38
Open
$235.36
50D MA
$206.67
Beta
0.72
Avg. Volume
927,837.23
EPS (Annual)
-$5.84
P/B
3.26
Rev/Employee
$1.48M
$13,352.18
Loading...
Loading...
News
all
press releases
Insider Decision: Rick E Winningham Exercises Options At Jazz Pharmaceuticals For $341K
read more...
Benzinga
News Placeholder
More News
News Placeholder
Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of...
PR Newswire
News Placeholder
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
News Placeholder
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls...
Yahoo! Finance: News
News Placeholder
Here Are Tuesday's Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-Energy, and More
Here Are Tuesday's Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-Energy, and More...
Yahoo! Finance: News
News Placeholder
Does Epidiolex Make Jazz Pharmaceuticals a Unique Cannabis Stock?
JAZZ gains unique cannabis exposure through Epidiolex as strong sales growth and patent protection boost long-term visibility.
Zacks
News Placeholder
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire DUBLIN, May 12, 2026 DUBLIN, May 12, 2026...
PR Newswire
News Placeholder
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
News Placeholder
International Markets and Jazz (JAZZ): A Deep Dive for Investors
Examine the evolution of Jazz's (JAZZ) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Zacks
News Placeholder
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available